Current Vascular Pharmacology
Title: Editorial [Hot topic: An Update on Venous Thromboembolism in Trauma, Orthopaedic and Reconstructive Surgery (Guest Editors: Peter V. Giannoudis and Panayotis N. Soucacos)]
Volume: 9 Issue: 1
Author(s): Peter V. Giannoudis and Panayotis N. Soucacos
Affiliation:
Export Options
About this article
Cite this article as:
V. Giannoudis Peter and N. Soucacos Panayotis, Editorial [Hot topic: An Update on Venous Thromboembolism in Trauma, Orthopaedic and Reconstructive Surgery (Guest Editors: Peter V. Giannoudis and Panayotis N. Soucacos)], Current Vascular Pharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157016111793744733
DOI https://dx.doi.org/10.2174/157016111793744733 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Specific Antidotes in Development for Reversal of Novel Anticoagulants: A Review
Recent Patents on Cardiovascular Drug Discovery Stem Cell Therapy for the Treatment of Myocardial Infarction
Current Pharmaceutical Design Prevention of Myocardial Damage During Coronary Intervention
Cardiovascular & Hematological Disorders-Drug Targets Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Current Pharmaceutical Design Development of Scaffolds for Vascular Tissue Engineering: Biomaterial Mediated Neovascularization
Current Stem Cell Research & Therapy Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology Development of New Fibrinolytic Agents
Current Pharmaceutical Design Pathophysiology of the Vascular Wall and its Relevance for Cerebrovascular Disorders in Aged Rodents
Current Neurovascular Research Mean Platelet Volume: A Link Between Thrombosis and Inflammation?
Current Pharmaceutical Design Analgesic Considerations for Liver Transplantation Patients
Current Clinical Pharmacology Update on Glycoprotein IIb/IIIa: Role in Primary Coronary Intervention
Cardiovascular & Hematological Agents in Medicinal Chemistry Hypercoagulability in Sickle Cell Disease and Beta-Thalassemia
Current Molecular Medicine Patent Foramen Ovale, the Role of Antiplatelet Therapy Alone or Anticoagulant Therapy Alone Versus Device Closure for Cryptogenic Stroke: A Review of the Literature and Current Recommendations
Cardiovascular & Hematological Agents in Medicinal Chemistry Myocardial Infarction with Non Obstructive Coronary Atherosclerosis: A Case Report
New Emirates Medical Journal The Unaddressed Issue of Optimal Antithrombotic Treatment after Coronary Artery Stenting in Patients with an Indication for Anticoagulation: Current Evidence and Suggested Practice
Vascular Disease Prevention (Discontinued) Potential New Targets for Antithrombotic Therapy
Current Pharmaceutical Design Heterogeneity of Synthetic Factor Xa Inhibitors
Current Pharmaceutical Design Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges
Current Drug Metabolism Assessment of Acute Coronary Syndromes: Focus on Novel Biomarkers
Current Medicinal Chemistry The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry